The settlement could be worth up to $12 billion.
of OxyContin has been sold by Purdue, with over $4 billion going to its owners since 2007. Over 100,000 Americans died from opioid addiction between 2006 to 2012. Purdue and three company executives previously pleaded guilty in 2007 to federal charges of misleading the public on OxyContin’s addictiveness between 1995 and 2001, according to theCollectively they paid over $630 million in penalties, with Purdue also signing a five-year corporate integrity agreement with the federal government.
from its walls, and the Metropolitan Museum of Art and the Guggenheim said in March they would no longer accept contributions from the family.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
WSJ News Exclusive | Purdue Pharma Made, Then Ditched, Plans for Opioid-Treatment NonprofitThe OxyContin maker nixed plans earlier this year to launch a foundation to fund opioid-addiction treatment and research as the company rethought its strategy amid hundreds of lawsuits and a possible bankruptcy filing.
Consulte Mais informação »
States split by party on accepting Purdue Pharma settlementRepublican state attorneys general across the U.S. largely line up in support of a tentative multibillion-dollar settlement with OxyContin maker Purdue Pharma, while their Democratic counterparts mostly oppose it.
Consulte Mais informação »
Purdue University faculty, students consider measure to prevent Chick-fil-A from opening on campusPurdue's University Senate Leadership will hold a vote in October regarding the fate of a proposed Chick-fil-A, expected to open on campus in 2020.
Consulte Mais informação »
Filings: Purdue owners used Swiss banks to hide transfersNEW YORK (AP) — The family that owns OxyContin maker Purdue Pharma used Swiss bank accounts to conceal the transfer of millions of dollars from the company to themselves, New York state's attorney...
Consulte Mais informação »
Exclusive: One Of The Largest Pharma Companies In The World Just Got Into CannabisAccording to information procured exclusively a subsidiary of NYSE-traded giant Teva Pharmaceuticals has signed a deal with medical cannabis company Canndoc to distribute its GMP products to pharma customers.
Consulte Mais informação »
Exclusive: One Of The Largest Pharma Companies In The World Just Got Into CannabisAccording to information procured exclusively a subsidiary of NYSE-traded giant Teva Pharmaceuticals has signed a deal with medical cannabis company Canndoc to distribute its GMP products to pharma customers.
Consulte Mais informação »